Gradient Investments’s Genomic Health, Inc. GHDX Stock Holding History

Gradient Investments’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-195	Closed	-$13K	–	1318
2019 Q3	$13K	Hold	195	–	–	﹤0.01%	619
2019 Q2	$11K	Hold	195	–	–	﹤0.01%	638
2019 Q1	$14K	Hold	195	–	–	﹤0.01%	509
2018 Q4	$13K	Buy	+195	New	+$13.7K	﹤0.01%	537
2018 Q1	–	Sell	-17	Closed	-$1K	–	1225
2017 Q4	$1K	Buy	+17	New	+$542	﹤0.01%	987

Gradient Investments's GHDX Position: Q4 2019 in Review

Gradient Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 195 shares — an estimated $13K sold.

Gradient Investments first reported a position in GHDX in Q4 2017 and held it in 5 quarters. The position peaked at $14K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Gradient Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Gradient Investments sold 195 Genomic Health, Inc. shares in Q4 2019, an estimated $13K.
Gradient Investments first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 5 quarters.
Gradient Investments's Genomic Health, Inc. position peaked at $14K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Gradient Investments's 13F filing for Q4 2019, filed 15 Jan 2020.